• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估观察性、实验性和医学研究中与大麻相关的精神病症状的发生率及预测因素。

Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research.

作者信息

Schoeler Tabea, Baldwin Jessie R, Martin Ellen, Barkhuizen Wikus, Pingault Jean-Baptiste

机构信息

Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.

Department of Clinical, Educational and Health Psychology, Division of Psychology and Language Sciences, University College London, London, UK.

出版信息

Nat Ment Health. 2024;2(7):865-876. doi: 10.1038/s44220-024-00261-x. Epub 2024 Jun 3.

DOI:10.1038/s44220-024-00261-x
PMID:39005547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11236708/
Abstract

Cannabis, one of the most widely used psychoactive substances worldwide, can give rise to acute cannabis-associated psychotic symptoms (CAPS). While distinct study designs have been used to examine CAPS, an overarching synthesis of the existing findings has not yet been carried forward. To that end, we quantitatively pooled the evidence on rates and predictors of CAPS ( = 162 studies,  = 210,283 cannabis-exposed individuals) as studied in (1) observational research, (2) experimental tetrahydrocannabinol (THC) studies, and (3) medicinal cannabis research. We found that rates of CAPS varied substantially across the study designs, given the high rates reported by observational and experimental research (19% and 21%, respectively) but not medicinal cannabis studies (2%). CAPS was predicted by THC administration (for example, single dose, Cohen's  = 0.7), mental health liabilities (for example, bipolar disorder,  = 0.8), dopamine activity ( = 0.4), younger age ( = -0.2), and female gender ( = -0.09). Neither candidate genes (for example, , ) nor other demographic variables (for example, education) predicted CAPS in meta-analytical models. The results reinforce the need to more closely monitor adverse cannabis-related outcomes in vulnerable individuals as these individuals may benefit most from harm-reduction efforts.

摘要

大麻是全球使用最广泛的精神活性物质之一,可引发急性大麻相关精神病性症状(CAPS)。虽然已采用不同的研究设计来研究CAPS,但尚未对现有研究结果进行全面综合分析。为此,我们对观察性研究、实验性四氢大麻酚(THC)研究以及药用大麻研究中关于CAPS发生率及预测因素的证据进行了定量汇总(n = 162项研究,n = 210,283名接触大麻的个体)。我们发现,不同研究设计中CAPS的发生率差异很大,观察性研究和实验性研究报告的发生率较高(分别为19%和21%),而药用大麻研究的发生率较低(2%)。THC给药(例如单剂量,Cohen's d = 0.7)、心理健康问题(例如双相情感障碍,d = 0.8)、多巴胺活性(d = 0.4)、较年轻年龄(d = -0.2)以及女性(d = -0.09)可预测CAPS。在荟萃分析模型中,候选基因(例如, , )和其他人口统计学变量(例如教育程度)均无法预测CAPS。这些结果强化了对易受伤害个体中与大麻相关的不良后果进行更密切监测的必要性,因为这些个体可能从减少伤害的措施中获益最多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/483c014c02ea/44220_2024_261_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/bbcd18c8ec20/44220_2024_261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/fc363c9081fa/44220_2024_261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/7e8aeb7b29c2/44220_2024_261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/109a9bb52031/44220_2024_261_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/8c6bae445807/44220_2024_261_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/483c014c02ea/44220_2024_261_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/bbcd18c8ec20/44220_2024_261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/fc363c9081fa/44220_2024_261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/7e8aeb7b29c2/44220_2024_261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/109a9bb52031/44220_2024_261_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/8c6bae445807/44220_2024_261_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1162/11236708/483c014c02ea/44220_2024_261_Fig6_HTML.jpg

相似文献

1
Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research.评估观察性、实验性和医学研究中与大麻相关的精神病症状的发生率及预测因素。
Nat Ment Health. 2024;2(7):865-876. doi: 10.1038/s44220-024-00261-x. Epub 2024 Jun 3.
2
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis.在超过 23 万名使用大麻的人群中,大麻相关精神病症状的发生率和相关因素。
Transl Psychiatry. 2022 Sep 6;12(1):369. doi: 10.1038/s41398-022-02112-8.
3
Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.评估支持针对有临床精神病高危风险的青少年采取大麻危害降低措施的证据:综述和临床实施工具。
Psychol Med. 2024 Jan;54(2):245-255. doi: 10.1017/S0033291723002994. Epub 2023 Oct 26.
4
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.首次精神病发作住院患者中的大麻和酒精滥用情况
Isr J Psychiatry Relat Sci. 2016;53(3):10-15.
5
Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies.药用大麻是否会影响癌症患者的抑郁、焦虑和压力?干预研究的系统评价和荟萃分析。
Maturitas. 2024 Jun;184:107941. doi: 10.1016/j.maturitas.2024.107941. Epub 2024 Feb 15.
6
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.用于治疗精神障碍及精神障碍症状的大麻素:一项系统评价与荟萃分析
Lancet Psychiatry. 2019 Dec;6(12):995-1010. doi: 10.1016/S2215-0366(19)30401-8. Epub 2019 Oct 28.
7
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.大麻影响的基因调节作用:儿茶酚-O-甲基转移酶(COMT)影响Δ9-四氢大麻酚(THC)对工作记忆表现的作用,但不影响精神病体验的发生。
J Psychopharmacol. 2015 Nov;29(11):1146-51. doi: 10.1177/0269881115609073. Epub 2015 Oct 13.
8
Adverse effects of cannabis.大麻的不良反应。
Prescrire Int. 2011 Jan;20(112):18-23.
9
Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity.Δ9-四氢大麻酚毒性及大麻二酚对脑多巴胺水平的验证:对大麻双重性的评估
Nat Prod Bioprospect. 2020 Oct;10(5):285-296. doi: 10.1007/s13659-020-00263-z. Epub 2020 Aug 28.
10
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.大麻使用对欧洲各地精神病性障碍发病率差异的影响(欧盟基因-环境相互作用研究):一项多中心病例对照研究。
Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.

本文引用的文献

1
Advice for improving the reproducibility of data extraction in meta-analysis.改善荟萃分析中数据提取可重复性的建议。
Res Synth Methods. 2023 Nov;14(6):911-915. doi: 10.1002/jrsm.1663. Epub 2023 Aug 11.
2
Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013-2020.2013 年至 2020 年期间,美国居民出于医疗目的使用大麻的比例不断增加。
Am J Prev Med. 2023 Sep;65(3):528-533. doi: 10.1016/j.amepre.2023.03.005. Epub 2023 Mar 12.
3
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.
对英国医用大麻登记处各患者群体的安全性和临床结局指标进行的一项观察性研究。
Expert Rev Clin Pharmacol. 2023 Mar;16(3):257-266. doi: 10.1080/17512433.2023.2183841. Epub 2023 Mar 3.
4
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.大麻及其与大麻二酚联合使用对成年人和青少年的急性影响:一项随机、双盲、安慰剂对照、交叉实验。
Addiction. 2023 Jul;118(7):1282-1294. doi: 10.1111/add.16154. Epub 2023 Feb 26.
5
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios.大麻素 CBD 是否使大麻更安全?四种不同 CBD:THC 比例的大麻的随机、双盲、交叉试验。
Neuropsychopharmacology. 2023 May;48(6):869-876. doi: 10.1038/s41386-022-01478-z. Epub 2022 Nov 16.
6
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis.在超过 23 万名使用大麻的人群中,大麻相关精神病症状的发生率和相关因素。
Transl Psychiatry. 2022 Sep 6;12(1):369. doi: 10.1038/s41398-022-02112-8.
7
The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.大麻二酚和 δ-9-四氢大麻酚对社会认知的影响:一项自然主义对照研究。
Cannabis Cannabinoid Res. 2024 Feb;9(1):230-240. doi: 10.1089/can.2022.0037. Epub 2022 Jul 26.
8
Individual and combined effects of cannabidiol and Δ-tetrahydrocannabinol on striato-cortical connectivity in the human brain.大麻二酚和 Δ-四氢大麻酚对人脑纹状体-皮质连接的单独和联合作用。
J Psychopharmacol. 2022 Jun;36(6):732-744. doi: 10.1177/02698811221092506. Epub 2022 May 20.
9
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.基因组定位研究提示精神分裂症的发病与基因及突触生物学有关。
Nature. 2022 Apr;604(7906):502-508. doi: 10.1038/s41586-022-04434-5. Epub 2022 Apr 8.
10
Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status.大麻与心理健康:心理健康状况对大麻使用的不良后果和自我报告影响。
Subst Use Misuse. 2022;57(5):719-729. doi: 10.1080/10826084.2022.2034872. Epub 2022 Feb 16.